These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10080337)

  • 41. Chronic inflammation from polycarbonate motility peg inhibits osteogenesis in a human hydroxyapatite orbital implant.
    Thakker MM; Zhang J; Sires BS
    Ophthalmic Plast Reconstr Surg; 2005 Sep; 21(5):399-401. PubMed ID: 16234714
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Osteogenesis with hematopoiesis simulating infection in a hydroxyapatite orbital implant.
    Jordan DR; Belliveau MJ; Brownstein S; Padmore RF
    Ophthalmic Plast Reconstr Surg; 2009; 25(1):72-4. PubMed ID: 19273939
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The influence of hyperbaric oxygen therapy and irradiation on hydroxyapatite ocular implant exposure and fibrovascular ingrowth in New Zealand white rabbits.
    DeBacker CM; Dutton JJ; Proia AD; Halperin EC; Wagle TN; Holck DE
    Ophthalmic Plast Reconstr Surg; 1999 Nov; 15(6):412-9. PubMed ID: 10588250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydroxyapatite orbital implants. Experience with 100 cases.
    McNab A
    Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Complications of hydroxyapatite orbital implants in children: a series of 105 cases].
    Lumbroso L; Levy C; Plancher C; Validire P; Asselain B; Doz F; Schlienger P; Desjardins L
    J Fr Ophtalmol; 2000 Mar; 23(3):249-54. PubMed ID: 10740051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Explanted polyethylene implants.
    Sandramouli S; Tambe K; Pushpoth S; Mudhar H
    Ophthalmology; 2010 Jan; 117(1):194-5; author reply 195. PubMed ID: 20114114
    [No Abstract]   [Full Text] [Related]  

  • 47. Primary placement of a hydroxyapatite-coated sleeve in bioceramic orbital implants.
    Liao SL; Shih MJ; Lin LL
    Am J Ophthalmol; 2005 Feb; 139(2):235-41. PubMed ID: 15733982
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyogenic granuloma as a presenting sign of hydroxyapatite orbital implant exposure: a clinicopathologic study.
    Owji N; Sadeghipour A; Salour H; Sahraeyan N
    Ophthalmic Plast Reconstr Surg; 2006; 22(6):467-71. PubMed ID: 17117104
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integrated hydroxyapatite implant and non-integrated implants in enucleated Asian patients.
    Chuah CT; Chee SP; Fong KS; Por YM; Choo CT; Luu C; Seah LL
    Ann Acad Med Singap; 2004 Jul; 33(4):477-83. PubMed ID: 15329760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Problems after evisceration surgery with porous orbital implants: experience with 86 patients.
    Jordan DR
    Ophthalmic Plast Reconstr Surg; 2004 Sep; 20(5):374-80. PubMed ID: 15377905
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gadolinium-enhanced magnetic resonance imaging assessment of hydroxyapatite orbital implants.
    Spirnak JP; Nieves N; Hollsten DA; White WC; Betz TA
    Am J Ophthalmol; 1995 Apr; 119(4):431-40. PubMed ID: 7535979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants.
    Arat YO; Shetlar DJ; Boniuk M
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):189-93. PubMed ID: 12918552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Problems with the hydroxyapatite orbital implant: experience with 250 consecutive cases.
    Shields CL; Shields JA; De Potter P; Singh AD
    Br J Ophthalmol; 1994 Sep; 78(9):702-6. PubMed ID: 7947552
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biocompatibility of a porous alumina orbital implant. Preliminary results of an animal experiment].
    Morel X; Rias A; Briat B; el Aouni A; D'Hermies F; Adenis JP; Legeais JM; Renard G
    J Fr Ophtalmol; 1998 Mar; 21(3):163-9. PubMed ID: 9759400
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term outcomes of pegged and unpegged bioceramic orbital implants.
    Karslıoğlu S; Buttanrı IB; Fazıl K; Serin D; Akbaba M
    Ophthalmic Plast Reconstr Surg; 2012; 28(4):264-7. PubMed ID: 22785584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endophthalmitis Associated With Glaucoma Drainage Implants.
    Medina CA; Butler MR; Deobhakta AA; Banitt MR; Albini TA; Smiddy WE; Berrocal AM; Gedde SJ; Flynn HW
    Ophthalmic Surg Lasers Imaging Retina; 2016 Jun; 47(6):563-9. PubMed ID: 27327286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term complications of different porous orbital implants: a 21-year review.
    Lin CW; Liao SL
    Br J Ophthalmol; 2017 May; 101(5):681-685. PubMed ID: 27474155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic hydroxyapatite orbital implants: a clinical and MRI evaluation.
    Sarvananthan N; Liddicoat AJ; Fahy GT
    Eye (Lond); 1999 Apr; 13 ( Pt 2)():205-8. PubMed ID: 10450382
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of chronic infection 28 years after silicone orbital implant.
    Miyasaka M; Tanaka R; Hanai U; Yamazaki A; Iida M; Akamatsu T
    Tokai J Exp Clin Med; 2008 Apr; 33(1):35-8. PubMed ID: 21318962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Combined rhinosinusogenic intracranial and orbital complication].
    Zav'ialov FN; Demidenko AN; Solodilova NM
    Vestn Otorinolaringol; 2009; (3):55-6. PubMed ID: 19705591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.